ID: ALA3400482

Max Phase: Preclinical

Molecular Formula: C16H13N3O3S

Molecular Weight: 327.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN(c1ccc2c(c1)OCO2)c1nc(=O)c2cccnc2s1

Standard InChI:  InChI=1S/C16H13N3O3S/c1-2-19(10-5-6-12-13(8-10)22-9-21-12)16-18-14(20)11-4-3-7-17-15(11)23-16/h3-8H,2,9H2,1H3

Standard InChI Key:  YQGZOEJHOSOQBZ-UHFFFAOYSA-N

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 327.37Molecular Weight (Monoisotopic): 327.0678AlogP: 2.94#Rotatable Bonds: 3
Polar Surface Area: 64.55Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.01CX LogP: 2.92CX LogD: 2.92
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.74Np Likeness Score: -1.19

References

1. Inami H, Shishikura J, Yasunaga T, Ohno K, Yamashita H, Kato K, Sakamoto S..  (2015)  Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists.,  23  (8): [PMID:25792143] [10.1016/j.bmc.2015.02.033]

Source